HELIUS MEDICAL TECHNOLOGIES (HSDT) Stock Price, Quote, News and Summary
NASDAQ:HSDT - Nasdaq - US42328V8019 - Common Stock
HSDT Quote and Key Statistics
HELIUS MEDICAL TECHNOLOGIES
NASDAQ:HSDT (1/21/2025, 8:06:04 PM)
After market: 0.9906 -0.04 (-3.83%)1.03
+0.28 (+37.15%)
HSDT Financial Highlights
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -158.62% | ||
| ROE | -233.19% | ||
| Debt/Equity | 0 |
HSDT Performance and Technical Analysis
HSDT Ownership and Analysts
HSDT Latest News and Analysis
These stocks are making the most noise in today's session. Stay tuned for the latest updates!
Stay updated with the latest market activity on Tuesday. Explore the most active stocks in today's session and stay informed about the stocks that are in the spotlight.
The market is filled with gapping stocks in Tuesday's session. Let's discover which stocks are showing gap-ups and gap-downs.
Today's session on Tuesday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.
Which stocks are moving before the opening bell on Tuesday?
Stay updated with the stocks that are on the move in Tuesday's pre-market session.
Wondering what's happening in today's pre-market session? Stay tuned for the latest updates on stock movements.
Get insights into the top gainers and losers of Wednesday's pre-market session.
Helius Medical Technologies, Inc. Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $3.7 Million Gross Proceeds Priced At-the-Market
Helius Medical Technologies, Inc. Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $3.7 Million Gross Proceeds Priced At-the-Market
NEWTOWN, Pa., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused...
About HSDT
Company Profile
Helius Medical Technologies, Inc. is a neurotech company in the medical device industry that focuses on neurological wellness. The company is headquartered in Newtown, Pennsylvania and currently employs 22 full-time employees. The company went IPO on 2014-06-27. The company is focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability to engage physiologic compensatory mechanisms enhancing the lives of people dealing with neurologic diseases. The company develops, licenses, or acquires non-implantable technologies targeted at reducing symptoms of neurological disease or trauma. Its product Portable Neuromodulation Stimulator (PoNS) is a non-implantable medical device, inclusive of a controller and mouthpiece, which delivers mild electrical stimulation to the surface of the tongue to provide treatment of gait deficit and chronic balance deficit. PoNS Therapy is integral to the overall PoNS solution and is the physical therapy applied by patients during use of the PoNS neuromodulation stimulator. PoNS is used as an adjunct to a supervised therapeutic exercise program in patients 22 years of age and over by prescription only.
Company Info
HELIUS MEDICAL TECHNOLOGIES
642 Newtown Yardley Road
Newtown PENNSYLVANIA 18940 US
CEO: Dane C. Andreeff
Employees: 22
Company Website: https://heliusmedical.com/
Investor Relations: https://heliusmedical.com/index.php/investor-relations/overview
Phone: 12159446100
HSDT Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ISRG | INTUITIVE SURGICAL INC | 89.9 | 215.18B | ||
| ABT | ABBOTT LABORATORIES | 25.84 | 202.57B | ||
| SYK | STRYKER CORP | 34.01 | 150.91B | ||
| BSX | BOSTON SCIENTIFIC CORP | 42.76 | 148.72B | ||
| MDT | MEDTRONIC PLC | 16.83 | 113.33B | ||
| BDX | BECTON DICKINSON AND CO | 18.27 | 69.71B | ||
| EW | EDWARDS LIFESCIENCES CORP | 26.21 | 41.27B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 20.7 | 39.90B | ||
| RMD | RESMED INC | 29.89 | 36.38B | ||
| IDXX | IDEXX LABORATORIES INC | 39.03 | 34.99B | ||
| DXCM | DEXCOM INC | 50.78 | 33.72B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 19.98 | 24.97B |